INe Van Hoyweghen
INe Van Hoyweghen
Professor, KU Leuven
Verified email at soc.kuleuven.be
TitleCited byYear
European practices of genetic information and insurance: lessons for the Genetic Information Nondiscrimination Act
I Van Hoyweghen, K Horstman
Jama 300 (3), 326-327, 2008
542008
Global trends on fears and concerns of genetic discrimination: a systematic literature review
A Wauters, I Van Hoyweghen
Journal of human genetics 61 (4), 275, 2016
452016
Risks in the making: travels in life insurance and genetics
I Van Hoyweghen
Amsterdam University Press, 2007
372007
Making genetics not so important: Family work in dealing with familial hypertrophic cardiomyopathy
E Geelen, I Van Hoyweghen, K Horstman
Social science & medicine 72 (11), 1752-1759, 2011
342011
Life insurance: genomic stratification and risk classification
Y Joly, H Burton, BM Knoppers, IN Feze, T Dent, N Pashayan, ...
European Journal of Human Genetics 22 (5), 575, 2014
332014
Unravelling fears of genetic discrimination: an exploratory study of Dutch HCM families in an era of genetic non-discrimination acts
E Geelen, K Horstman, CLM Marcelis, PA Doevendans, I Van Hoyweghen
European Journal of Human Genetics 20 (10), 1018, 2012
332012
Making the normal deviant: The introduction of predictive medicine in life insurance
I Van Hoyweghen, K Horstman, R Schepers
Social Science & Medicine 63 (5), 1225-1235, 2006
282006
Genetic ‘risk carriers’ and lifestyle ‘risk takers’. Which risks deserve our legal protection in insurance?
I Van Hoyweghen, K Horstman, R Schepers
Health Care Analysis 15 (3), 179-193, 2007
272007
The paradox of public health genomics: definition and diagnosis of familial hypercholesterolaemia in three European countries
E Aarden, I Van Hoyweghen, K Horstman
Scandinavian journal of public health 39 (6), 634-639, 2011
262011
On the politics of calculative devices: performing life insurance markets
I Van Hoyweghen
Journal of Cultural Economy 7 (3), 334-352, 2014
212014
Constructing “best interests”: Genetic testing of children in families with hypertrophic cardiomyopathy
E Geelen, I Van Hoyweghen, PA Doevendans, CLM Marcelis, K Horstman
American Journal of Medical Genetics Part A 155 (8), 1930-1938, 2011
212011
Taming the wild life of genes by law? Genes reconfiguring solidarity in private insurance
I Van Hoyweghen
New Genetics and Society 29 (4), 431-455, 2010
192010
Reflections on different governance styles in regulating science: a contribution to ‘Responsible Research and Innovation’
L Landeweerd, D Townend, J Mesman, I Van Hoyweghen
Life sciences, society and policy 11 (1), 8, 2015
182015
Providing preimplantation genetic diagnosis in the United Kingdom, The Netherlands and Germany: a comparative in-depth analysis of health-care access
E Aarden, I Van Hoyweghen, R Vos, K Horstman
Human reproduction 24 (7), 1542-1547, 2009
152009
‘Genetics is not the issue’: Insurers on genetics and life insurance
I Van Hoyweghen, K Horstman, R Schepers
New Genetics and Society 24 (1), 79-98, 2005
152005
Enacting actuarial fairness in insurance: From fair discrimination to behaviour-based fairness
G Meyers, I Van Hoyweghen
Science as Culture 27 (4), 413-438, 2018
122018
Learning from co-evolution of policy and technology. Different PGDs in the Netherlands, Germany and Britain
E Aarden, I Van Hoyweghen, K Horstman, R Vos
Journal of Comparative Policy Analysis: Research and Practice 10 (2), 191-206, 2008
112008
Insurance and the economization of uncertainty
TK Lehtonen, I Van Hoyweghen
Journal of Cultural Economy 7 (4), 532-540, 2014
92014
Constructing access in predictive medicine. Comparing classification for hereditary breast cancer risks in England, Germany and the Netherlands
E Aarden, I Van Hoyweghen, K Horstman
Social Science & Medicine 72 (4), 553-559, 2011
92011
Evidence-based underwriting in the molecular age: the politics of reinsurance companies towards the genetics issue
I Van Hoyweghen, K Horstman
New Genetics and Society 28 (4), 317-337, 2009
92009
The system can't perform the operation now. Try again later.
Articles 1–20